trishulatx.com
Get leads like Trishulatx — and thousands more
Build targeted lists by tech stack, traffic, and more
Trishula: The Stealth Biotech Disrupting Cancer Immunotherapy
A lean team, a first-in-class antibody, and a bold bet on CD39 inhibition
In the crowded battlefield of oncology biotech, Trishula Therapeutics isn't shouting the loudest—it's building the most precise weapon. With just 18 employees and a first-in-class anti-CD39 antibody, they're challenging the giants of immunotherapy.
"In biotech, size is often mistaken for substance. Trishula proves that strategic focus beats brute force."
The CD39 Playbook
TTX-030 targets CD39, a key enzyme in the immunosuppressive adenosine pathway. While big pharma chases PD-1/PD-L1 exhaustion, Trishula is betting that blocking CD39 will reinvigorate T-cells more effectively. It's a calculated risk in a $100B+ oncology market.
The Talent Equation
With leadership from AstraZeneca alumni and C-suite veterans, Trishula's 18-person team punches above its weight. The LinkedIn-driven traffic (44% direct) suggests a network-driven recruitment strategy, likely targeting biotech insiders rather than mass-market hiring.
The website's minimal traffic (1,371 monthly visits) is deceptive. For a preclinical biotech, this isn't a weakness—it's a sign of focused, high-value engagement. No flashy marketing, no mass awareness campaigns. Just pure, technical content for investors, partners, and the right talent.
- First-in-class anti-CD39 antibody in development
- Revenue-generating biotech ($2.8M) without public funding rounds
- Leadership team with deep AstraZeneca and biotech experience
- Hyper-focused digital presence—no wasted traffic
The Quiet Giant in Immunotherapy
Trishula isn't building a brand—it's building a pipeline. And in biotech, that's the only metric that matters.
What tech stack does Trishulatx use?
How much traffic does Trishulatx get?
Traffic & Engagement
Traffic Sources
Where is Trishulatx's audience located?
What keywords does Trishulatx rank for?
5 keywordsHow is Trishulatx's SEO?
Meta Tags
TTX-030 | anti-CD39 antibody | Trishula Therapeutics
Trishula Therapeutics is dedicated to improving outcomes for people with cancer by developing TTX-030, a first-in-class anti-CD39 antibody.
H1 Tags
What is Trishulatx's revenue?
Who works at Trishulatx?
Loading leads...
What do customers think of Trishulatx?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Trishulatx
What is Trishulatx's Revenue?
What does Trishulatx do?
How fast is Trishulatx growing?
What technologies does Trishulatx use?
Who are Trishulatx's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Trishulatx?
Social Profiles
Contact Information
Export trishulatx.com Data
Download the complete tech stack, analytics, leads, and company data for trishulatx.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About trishulatx.com
Trishula Therapeutics is dedicated to improving outcomes for people with cancer by developing TTX-030, a first-in-class anti-CD39 antibody.
Company Overview
trishulatx.com Social Media
Contact trishulatx.com
Phone Numbers
Technology Stack
trishulatx.com uses 2 technologies across their website including Google Analytics, jQuery.
Analytics & Marketing
Google Analytics
JavaScript Libraries
jQuery
Traffic & Audience
trishulatx.com receives approximately 1.4K monthly visitors and ranks #10,542,695 globally. The website has a bounce rate of 51% with visitors viewing an average of 1.9 pages per visit. Users spend an average of 0:18 on the site.
The majority of trishulatx.com's traffic comes from undefined, .
Frequently Asked Questions
What is trishulatx.com?
What technologies does trishulatx.com use?
How do I contact trishulatx.com?
What are trishulatx.com's social media accounts?
Is trishulatx.com hiring?
How popular is trishulatx.com?
Related Searches
This page provides publicly available information about trishulatx.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit trishulatx.com directly at https://trishulatx.com.